Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biomedical Research and Therapy is Scopus-indexed (Q3, CiteScore 1.1), WoS ESCI. Published by BiomedPress.
Checked against the index lists dated .
ISSN 2198-4093Verify ISSN ↗
Publisher: BiomedPress
Cost to publish: No APC data — check the publisher
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Medicine (all) | 359 / 669 | 46th | Q3 |
| Biochemistry, Genetics and Molecular Biology (all) | 183 / 223 | 18th | Q4 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018 (also 2020–present), best quartile Q3, CiteScore 1.1.
Biomedical Research and Therapy is Q3 in Medicine (all) (rank 359 of 669) and Q4 in Biochemistry, Genetics and Molecular Biology (all) (rank 183 of 223), by CiteScore 2025.
Biomedical Research and Therapy is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 1.1, which places it in quartile Q3 at the 46th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.229, quartile Q4, with an H-index of 13.
Biomedical Research and Therapy is published by BiomedPress. Its ISSN is 2198-4093.
Yes — indexed in the Emerging Sources Citation Index.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Biomedical Research and Therapy has an h-index of 28 and a 2-year mean of 1.11 citations per paper (OpenAlex). Its Scopus CiteScore is 1.1, quartile Q3. On 2-year citations it ranks #237 of 646 Scopus journals in Medicine (all).
Biomedical Research and Therapy published 89 papers in 2025; its busiest recent year was 2017 with 206. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 95 research articles (2025–2026), authors are most often from India (21.6%), Vietnam (16.7%) and Malaysia (13.9%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.